Royal Bank Of Canada Bio Line Rx Ltd. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Royal Bank Of Canada holds 20,200 shares of BLRX stock, worth $74,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,200Holding current value
$74,942% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding BLRX
# of Institutions
37Shares Held
3.95MCall Options Held
46.5KPut Options Held
6.3K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.75 Million0.05% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$3.03 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$617,5250.02% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$583,2670.37% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$349,2330.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $228M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...